FDA sees 'appropriate' transition period for COVID-19 test EUAs when public health emergency ends

The FDA is seeking to reassure COVID-19 test manufacturers that their products with emergency use authorizations will not be abruptly left high and dry, as the pandemic’s acute phase seems to be drawing to a close.